Literature DB >> 10815025

HSV-2 specific serology should be offered routinely to antenatal patients.

Z A Brown1.   

Abstract

The most devastating consequence of genital herpes is neonatal herpes. It is clear that the majority of newborns acquire their infection by contact with infected genital secretions during delivery from an asymptomatic mother who acquired a first episode of genital herpes near the time of labour. Since the majority of cases of first episode genital herpes during pregnancy are unrecognised, the prevention of neonatal transmission will depend upon the identification of the HSV serologically discordant couple and the institution of appropriate interventions by mid pregnancy. Therefore, the précis of this discussion paper is that universal HSV serological testing should be performed at the first prenatal visit. As a corollary, type specific HSV serology will need to be commercially available and relatively inexpensive. In any country, pregnant women and their partners represent a broad, cross section of sexually active adults. The vast majority present themselves to the health care system for care during their pregnancies which is a period of time in which the focus of care is primarily preventive and during which women are generally motivated and compliant. This is truly the 'golden opportunity' to identify patients already infected as well as those at risk for acquiring genital herpes. Information regarding genital herpes and methods of preventing transmission to susceptible partners and newborn infants can easily be added to educational programmes which have already become an institution within prenatal care. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10815025     DOI: 10.1002/(sici)1099-1654(200005/06)10:3<141::aid-rmv280>3.0.co;2-2

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  13 in total

Review 1.  Sorting out the new HSV type specific antibody tests.

Authors:  R L Ashley
Journal:  Sex Transm Infect       Date:  2001-08       Impact factor: 3.519

2.  Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.

Authors:  Hayley D Mark; Joy P Nanda; Jessica Roberts; Anne Rompalo; Johan H Melendez; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

3.  The potential role of suppressive therapy for sex partners in the prevention of neonatal herpes: a health economic analysis.

Authors:  R V Barnabas; H Carabin; G P Garnett
Journal:  Sex Transm Infect       Date:  2002-12       Impact factor: 3.519

Review 4.  Diagnostics for herpes simplex virus: is PCR the new gold standard?

Authors:  Lara B Strick; Anna Wald
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

5.  The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.

Authors:  S L Rosenthal; G D Zimet; J S Leichliter; L R Stanberry; K H Fife; W Tu; D I Bernstein
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

6.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

7.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 8.  Vertical transmission of genital herpes: prevention and treatment options.

Authors:  Cheryl A Jones
Journal:  Drugs       Date:  2009       Impact factor: 9.546

9.  Regional distribution of antibodies to herpes simplex virus type 1 (HSV-1) and HSV-2 in men and women in Ontario, Canada.

Authors:  Michelle Howard; John W Sellors; Dan Jang; Noah J Robinson; Margaret Fearon; Janusz Kaczorowski; Max Chernesky
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

10.  Use of a fragment of glycoprotein G-2 produced in the baculovirus expression system for detecting herpes simplex virus type 2-specific antibodies.

Authors:  Minako Ikoma; Jan-Ake Liljeqvist; Jan Groen; Koen L Glazenburg; T Hauw The; Sytske Welling-Wester
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.